"The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients"

"The Impact of Enteral Immunonutrition on Gut Microbiota, Intestinal Permeability, and Inflammation of Intestines in Colorectal Cancer as Well as Gastric Cancer Patients - a Randomized Trials"

Enteral immunomodulating nutrition modifies the gastrointestinal microbiota as well as improves the intestinal barrier integrity in patients with gastric and colorectal cancer in the perioperative period. As a consequence, it contributes to the reduction of the incidence of postoperative complications and diarrhea, which is a side effect of anti-cancer treatment often used preoperatively in this group of cancers.

Inclusion Criteria:

• age >18 y.o.
• patients with gastric or colorectal cancer
• patients treated in Department of Surgical Oncology, Medical University of Gdańsk
• patients' agreement to take part in this study

Exclusion Criteria:

• age <18 y.o.
• other types of cancer than gastric/colorectal cancer
• the presence of inflammatory bowel disease
• pregnancy